Anti-UGT1A1 monoclonal antibody

Pre-made anti-UGT1A1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to UGT1A1/UGT1A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0035-Ab-1/ GM-Tg-hg-IP0035-Ab-2Anti-Human UGT1A1 monoclonal antibodyHuman
GM-Tg-rg-IP0035-Ab-1/ GM-Tg-rg-IP0035-Ab-2Anti-Rat UGT1A1 monoclonal antibodyRat
GM-Tg-mg-IP0035-Ab-1/ GM-Tg-mg-IP0035-Ab-2Anti-Mouse UGT1A1 monoclonal antibodyMouse
GM-Tg-cynog-IP0035-Ab-1/ GM-Tg-cynog-IP0035-Ab-2Anti-Cynomolgus/ Rhesus macaque UGT1A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0035-Ab-1/ GM-Tg-felg-IP0035-Ab-2Anti-Feline UGT1A1 monoclonal antibodyFeline
GM-Tg-cang-IP0035-Ab-1/ GM-Tg-cang-IP0035-Ab-2Anti-Canine UGT1A1 monoclonal antibodyCanine
GM-Tg-bovg-IP0035-Ab-1/ GM-Tg-bovg-IP0035-Ab-2Anti-Bovine UGT1A1 monoclonal antibodyBovine
GM-Tg-equg-IP0035-Ab-1/ GM-Tg-equg-IP0035-Ab-2Anti-Equine UGT1A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0035-Ab-1/ GM-Tg-hg-IP0035-Ab-2; GM-Tg-rg-IP0035-Ab-1/ GM-Tg-rg-IP0035-Ab-2;
GM-Tg-mg-IP0035-Ab-1/ GM-Tg-mg-IP0035-Ab-2; GM-Tg-cynog-IP0035-Ab-1/ GM-Tg-cynog-IP0035-Ab-2;
GM-Tg-felg-IP0035-Ab-1/ GM-Tg-felg-IP0035-Ab-2; GM-Tg-cang-IP0035-Ab-1/ GM-Tg-cang-IP0035-Ab-2;
GM-Tg-bovg-IP0035-Ab-1/ GM-Tg-bovg-IP0035-Ab-2; GM-Tg-equg-IP0035-Ab-1/ GM-Tg-equg-IP0035-Ab-2
Products NameAnti-UGT1A1 monoclonal antibody
Formatmab
Target NameUGT1A1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-UGT1A1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0035-Ag-1Recombinant multi-species UD11/ UGT1A1/ BILIQTL1 protein
    ORF Viral VectorvGMAP000477Human UGT1A1 Adenovirus particle
    ORF Viral VectorpGMAP000477Human UGT1A1 Adenovirus plasmid
    ORF Viral VectorpGMLPm002737mouse Ugt1a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002737mouse Ugt1a1 Lentivirus particle


    Target information

    Target IDGM-IP0035
    Target NameUGT1A1
    Gene ID54658,24861
    Gene Symbol and SynonymsBILIQTL1,GNT1,HUG-BR1,UDPGT,UDPGT 1-1,UGT1,UGT1A,UGT1A1
    Uniprot AccessionP22309,Q64550
    Uniprot Entry NameUD11_HUMAN,UD11_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000241635
    Target ClassificationTumor-associated antigen (TAA)

    The target: UGT1A1, gene name: UGT1A1, also named as BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT 1-1, UGT1, UGT1A. This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.